Do Patients With Advanced Urothelial Carcinoma Benefit From Weekly Paclitaxel Chemotherapy? A GETUG Phase II Study-Reference-Cited by-同舟云学术

Do Patients With Advanced Urothelial Carcinoma Benefit From Weekly Paclitaxel Chemotherapy? A GETUG Phase II Study

Published:2009-08 Issue:2 Volume:7 Page:E28-E33
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Joly Florence,Houédé Nadine,Noal Sabine,Chevreau Christine,Priou Frank,Chinet-Charrot Paule,Rolland Frédéric,Fléchon Aude,Henry-Amar Michel,Culine Stéphane

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference30 articles.

1. The present and future of combination chemotherapy in bladder cancer;Culine;Semin Oncol,2002

2. Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer;von der Maase;J Clin Oncol,2005

3. Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy;Bajorin;J Clin Oncol,1999

4. Paclitaxel in the treatment of advanced urothelial cancer;Bajorin;Oncology (Williston Park),2000

5. Progress in the chemotherapy of metastatic cancer of the urinary tract;Raghavan;Cancer,2003

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functionalized Polymeric Micelles for Targeted Cancer Therapy: Steps from Conceptualization to Clinical Trials;Pharmaceutics;2024-08-06

2. Results from a Phase 1b/2 Study of Ibrutinib Combination Therapy in Advanced Urothelial Carcinoma;Cancers;2023-05-30

3. Radiotherapy in Metastatic Urothelial Carcinoma: Rationale and Clinical Applications;Anticancer Research;2022-07-26

4. Recent therapeutic advances in urothelial carcinoma: A paradigm shift in disease management;Critical Reviews in Oncology/Hematology;2022-06

5. Changes in the treatment landscape for metastatic urothelial cancer: current therapy and future directions;Journal of Men's Health;2022-05-06